文献速递白血病

唐氏综合征儿童急性淋巴细胞白血病的遗传易感性研究

Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
PubMed 文献 · Blood · 2019-01-01

本研究首次对唐氏综合征(DS)相关急性淋巴细胞白血病(ALL)进行全基因组关联研究,荟萃分析4项独立研究,包含542例DS-ALL病例和1192例DS对照。识别出4个全基因组显著易感位点:IKZF1附近rs58923657(OR=2.02)、CDKN2A内rs3731249(OR=3.63)、ARID5B内rs7090445(OR=1.60)和GATA3内rs3781093(OR=1.73)。病例-病例分析显示CDKN2A风险等位基因在DS儿童中渗透性增高(OR=1.58)。

要点

  • DS-ALL患者中CDKN2A风险位点rs3731249的OR为3.63,高于其他位点。
  • CDKN2A风险等位基因在DS儿童中渗透性增高,校正CRLF2过表达后仍显著。
  • IKZF1风险位点定位于B细胞超级增强子,风险等位基因与增强子活性降低相关。

核心结论

  • CDKN2A风险位点在DS儿童中渗透性增高,为DS-ALL病因学提供进一步生物学基础。

研究设计与样本

  • 首个DS-ALL全基因组关联研究,荟萃分析4项独立研究,纳入542例DS-ALL病例和1192例DS对照。

主要发现

  • 识别出4个全基因组显著易感位点:rs58923657(IKZF1附近,OR=2.02,Pmeta=5.32×10-15)、rs3731249(CDKN2A内,OR=3.63,Pmeta=3.91×10-10)、rs7090445(ARID5B内,OR=1.60,Pmeta=8.44×10-9)和rs3781093(GATA3内,OR=1.73,Pmeta=2.89×10-8)。
  • DS-ALL与非DS ALL病例-病例分析中,CDKN2A风险等位基因频率与DS状态显著相关(OR=1.58,Pmeta=4.1×10-4)。
  • CDKN2A关联在校正或分层CRLF2过表达及其他分子亚组的回归模型中仍保持,提示DS儿童中CDKN2A风险等位基因渗透性增高。
  • IKZF1风险位点定位于B细胞超级增强子,风险等位基因与增强子活性降低及差异蛋白结合相关。
  • IKZF1敲低导致DS淋巴母细胞样细胞系增殖显著高于非DS细胞系。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Children with Down syndrome (DS) have a 20-fold increased risk of acute lymphoblastic leukemia (ALL) and distinct somatic features, including CRLF2 rearrangement in ∼50% of cases; however, the role of inherited genetic variation in DS-ALL susceptibility is unknown. We report the first genome-wide association study of DS-ALL, comprising a meta-analysis of 4 independent studies, with 542 DS-ALL cases and 1192 DS controls. We identified 4 susceptibility loci at genome-wide significance: rs58923657 near IKZF1 (odds ratio [OR], 2.02; Pmeta = 5.32 × 10-15), rs3731249 in CDKN2A (OR, 3.63; Pmeta = 3.91 × 10-10), rs7090445 in ARID5B (OR, 1.60; Pmeta = 8.44 × 10-9), and rs3781093 in GATA3 (OR, 1.73; Pmeta = 2.89 × 10-8). We performed DS-ALL vs non-DS ALL case-case analyses, comparing risk allele frequencies at these and other established susceptibility loci (BMI1, PIP4K2A, and CEBPE) and found significant association with DS status for CDKN2A (OR, 1.58; Pmeta = 4.1 × 10-4). This association was maintained in separate regression models, both adjusting for and stratifying on CRLF2 overexpression and other molecular subgroups, indicating an increased penetrance of CDKN2A risk alleles in children with DS. Finally, we investigated functional significance of the IKZF1 risk locus, and demonstrated mapping to a B-cell super-enhancer, and risk allele association with decreased enhancer activity and differential protein binding. IKZF1 knockdown resulted in significantly higher proliferation in DS than non-DS lymphoblastoid cell lines. Our findings demonstrate a higher penetrance of the CDKN2A risk locus in DS and serve as a basis for further biological insights into DS-ALL etiology.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Brown AL, de Smith AJ, Gant VU, et al. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome. Blood. 2019. PMID: 31350265. doi:10.1182/blood.2018890764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。